ContributorsPublishersAdvertisers

Dr. Raghav on Treatment Considerations With Regorafenib and TAS-102 in CRC

onclive.com
 2021-12-03

Kanwal Raghav, MBBS, MD, discusses the safety profiles of regorafenib and trifluridine/tipiracil, and selecting between the agents for the treatment of patients with colorectal cancer. Kanwal Raghav, MBBS, MD, associate professor, Department of Gastrointestinal Medical Oncology, Division of Cancer...

www.onclive.com

Comments / 0

Comments / 0